Latest News

The company receives USD10 million in near-term milestones and stands to earn up to USD 705 million additional milestone payments upon reaching key development and regulatory benchmarks.

The collaboration centers on developing targeted radiopharmaceuticals that leverage Regeneron’s antibody portfolio and VelocImmune mice technology.

The recall specifically affects Azithromycin 500mg USP Tablets, Batch Number 24050191.

Zora brings a wealth of experience from his 15-year journey within Philips, during which he has established himself as a trusted leader across multiple markets in the region.

Varipulse Pro will receive prominent visibility at the European Heart Rhythm Association (EHRA) annual meeting, where J&J plans to conduct live procedure demonstrations and offer practical training sessions for healthcare professionals.

Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, and Qiming Venture Partners co-led the financing initiative.

Companies can now settle renewal fees through structured payment plans, with options to extend payments until 30 September 2026.

The government has set a bold target: by 2030, Egypt will manufacture 140 million human vaccine doses per year.

The South African Health Products Regulatory Authority officially approved Lenacapavir, branded as Sunlenca, on October 27, 2025, making South Africa the first African country to authorize this innovation.

The donation includes a hydraulic integrated operating table, a stainless steel instrument table, a manual wheelchair, and a surgical operating lamp.